234 related articles for article (PubMed ID: 22531380)
1. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of ticagrelor derivatives as novel antiplatelet agents.
Zhang H; Liu J; Zhang L; Kong L; Yao H; Sun H
Bioorg Med Chem Lett; 2012 Jun; 22(11):3598-602. PubMed ID: 22546677
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and inhibitory activities on platelet aggregation of some flavonoid analogues.
Göker H; Tunçbilek M; Leoncini G; Buzzi E; Mazzei M; Rolland Y; Ertan R
Arzneimittelforschung; 1995 Feb; 45(2):150-5. PubMed ID: 7710437
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
6. New platelet aggregation inhibitors based on pyridazinone moiety.
Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
8. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
Rehse K; Baselt T
Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
Jordão AK; Ferreira VF; Lima ES; de Souza MC; Carlos EC; Castro HC; Geraldo RB; Rodrigues CR; Almeida MC; Cunha AC
Bioorg Med Chem; 2009 May; 17(10):3713-9. PubMed ID: 19380229
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and platelet aggregation inhibitory effects of N-[(1H-pyrazol-1-yl)alkyl]benzoylamides.
Ferroni R; Milani L; Simoni D; Orlandini P; Bottura M; Bardi A; Guarneri M
Arzneimittelforschung; 1990 Jun; 40(6):705-9. PubMed ID: 2397007
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives.
Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN
Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
13. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
Rehse K; Kotthaus J; Khadembashi L
Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
15. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
16. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
[TBL] [Abstract][Full Text] [Related]
17. A comparative optical aggregometry study of antiplatelet activity of taxanes from Taxus cuspidata.
Kim SY; Yun-Choi HS
Thromb Res; 2010 Jun; 125(6):e281-4. PubMed ID: 20170941
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Liu XJ; Shi TE; Wang X; Wei TT; Meng X
Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of ferulic acid derivatives and their inhibitory effect on platelet aggregation].
Li JM; Zhao YH; Zhong GC; Long ZJ; Zhou P; Yuan M
Yao Xue Xue Bao; 2011 Mar; 46(3):305-10. PubMed ID: 21626785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
